Tests for autism? Companies are selling them, but research is still scant

The new tests for autism are not yet reliable enough to be offered commercially. None of the tests has gone through large ...
Yahoo Finance

Autism Commercial and Clinical Assessment Report 2025: Insights Into the Pipeline, Drugs, Companies, and Unmet Needs

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Autism - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering. This report outlays comprehensive insights of ...
Yahoo Finance

Autism Pipeline Insights Report, 2024: Analysis of Emerging Therapies, Key Players, Unmet Needs and More

Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Autism - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. This report outlays comprehensive insights of ...
Disability Scoop

Autism Speaks Looks To Commercial Market

The nation’s largest autism organization is launching a secondary entity with an eye toward bringing everything from medical innovations to apps for those on the spectrum to market. Officials at ...
Seeking Alpha

Beyond Air® Licenses Commercial Rights to Selective Neuronal Nitric Oxide Synthase (nNOS) Inhibitors for the Treatment of Autism Spectrum Disorder from Hebrew University of ...

GARDEN CITY, N.Y., June 15, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the ...